Dicle Yavuz / Istanbul Temmuz July 27 (Hibya) - Covid-19c, developed by biotechnology organizations Moderna and a part of the National Institute of Allergy and Infectious Diseases and National Institutes of Health.
According to Moderna test tests at this stage will take place in about 100 research sites of the USA.
According to the CNN Health report, as a result of the studies to be conducted with approximately 30،000 adult volunteers, the symptomatic normemia of the Moderna / NIH vaccine after two doses, among other results.
Within the scope of the studies, volunteers will receive approximately 100 micrograms of vaccine or a placebo injection approximately 28 days apart ؛ investigators and participants will not know who received the vaccine.
The first phase of the ، vaccine published in the New England Journal of Medicine earlier this month
The results indicated that gönüllü immune responses are generally safe in all volunteers. Only mild side effects such as ، fatigue ، tremor ، headache ، muscle pain and pain at the injection site were recorded.
Hibya Haber Ajansı
Yorumlar
Kalan Karakter: